Concepedia

Ahsan Rizwan

AR

7

Publications

398

Citations

7

H-Index

2004

Active since

Affiliations

University of Göttingen(Current)

The University of Texas MD Anderson Cancer Center

Ahsan Rizwan is an author at University of Göttingen specializing in medicine, natural sciences, and cellular biochemistry.

ORCID

Top concepts

Publications per year

2004–2023

7

Publications

7

Bempegaldesleukin (NKTR-214) plus Nivolumab in Patients with Advanced Solid Tumors: Phase I Dose-Escalation Study of Safety, Efficacy, and Immune Activation (PIVOT-02)

Adi Diab, Nizar M. Tannir, Salah-Eddine Bentebibel et al. · Cancer Discovery · 2020 · 231 citations · Full text

The Chloride Dependence of the Human Organic Anion Transporter 1 (hOAT1) Is Blunted by Mutation of a Single Amino Acid

Ahsan Rizwan, Wolfgang Krick, Gerhard Burckhardt · Journal of Biological Chemistry · 2007 · 48 citations · Full text

, , +16

AdvanTIG-105: a phase I dose escalation study of the anti-TIGIT monoclonal antibody ociperlimab in combination with tislelizumab in patients with advanced solid tumors

Sophia Frentzas, Steven Kao, Rang Gao et al. · Journal for ImmunoTherapy of Cancer · 2023 · 40 citations · Full text

Reconstructing a Chloride-binding Site in a Bacterial Neurotransmitter Transporter Homologue

Sotiria Tavoulari, Ahsan Rizwan, Lucy R. Forrest et al. · Journal of Biological Chemistry · 2010 · 34 citations · Full text

NKTR-214 + nivolumab in first-line advanced/metastatic urothelial carcinoma (mUC): Updated results from PIVOT-02.

Arlene O. Siefker‐Radtke, Mayer Fishman, Arjun Vasant Balar et al. · Journal of Clinical Oncology · 2019 · 22 citations

, , +19

Rows per page

1–5 of 7